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The C30 carotene synthase CrtM from Staphylococcus aureus and the C40 carotene synthase CrtB from
Erwinia uredovora were swapped into their respective foreign C40 and C30 biosynthetic pathways (heterolo-
gously expressed in Escherichia coli) and evaluated for function. Each displayed negligible ability to synthesize
the natural carotenoid product of the other. After one round of mutagenesis and screening, we isolated 116
variants of CrtM able to synthesize C40 carotenoids. In contrast, we failed to find a single variant of CrtB with
detectable C30 activity. Subsequent analysis revealed that the best CrtM mutants performed comparably to
CrtB in an in vivo C40 pathway. These mutants showed significant variation in performance in their original
C30 pathway, indicating the emergence of enzymes with broadened substrate specificity as well as those with
shifted specificity. We discovered that Phe 26 alone determines the specificity of CrtM. The plasticity of CrtM
with respect to its substrate and product range highlights the potential for creating further new carotenoid
backbone structures.
A common feature of secondary metabolism is the extensive
use of enzymes with broad substrate and product specificities.
Many isoprenoid biosynthetic enzymes, for example, accept a
variety of both natural and unnatural substrates (37, 38, 41).
Some have been shown to synthesize an impressively large
number of compounds (sometimes 50) from a single sub-
strate (12, 17, 55). Secondary metabolic pathways also use
enzymes with remarkably stringent specificity. Such enzymes
are frequently seen in key determinant positions, usually in the
very early steps of a pathway, while promiscuous enzymes tend
to be located further downstream. Thus, many secondary path-
ways have a “reverse tree” topology (3, 52), where the back-
bone structures of metabolites are dictated by a small number
of stringent, upstream enzymes. When the substrate or product
preferences of these key upstream enzymes are altered, path-
way branches leading to sets of novel compounds may be
opened (13). Our interest is to achieve the same by applying
methods of directed enzyme evolution to recombinant path-
ways in Escherichia coli (53, 61).
Among the most widespread of all secondary metabolites,
carotenoids are natural pigments that play important biological
roles. Some are accessory light-harvesting components of pho-
tosynthetic systems, while others are photoprotecting antioxi-
dants or regulators of membrane fluidity. Recent studies ad-
vocate their effectiveness in preventing cancer and heart
disease (36), as well as their potential hormonal activity (5, 25).
Such diverse molecular functions justify exploring rare or novel
carotenoid structures. At present, 700 carotenoids from the
naturally occurring C30 and C40 carotenoid biosynthetic path-
ways have been characterized (24). Most natural carotenoid
diversity arises from differences in types and levels of desatu-
ration and other modifications of the C40 backbone. C40 caro-
tenoids are also much more widespread in nature than their
C30 counterparts. The former are synthesized by thousands of
plant and microbial species, whereas the latter are known only
in a select few bacteria (56, 59). Homocarotenoids (carote-
noids with 40 carbon atoms) and apocarotenoids (carote-
noids with 40 carbon atoms), which result from the action of
downstream enzymes on a C40 substrate, are also known. Al-
though these structures do not have 40 carbon atoms, they are
nonetheless derived from C40 carotenoid precursors (6).
The first committed step in carotenoid biosynthesis is the
head-to-head condensation of two prenylpyrophosphates cat-
alyzed by a synthase enzyme (Fig. 1). The C40 carotenoid
phytoene is synthesized by the condensation of two molecules
of geranylgeranylpyrophosphate (GGPP) catalyzed by the syn-
thase CrtB. C30 carotenoids are synthesized via an indepen-
dent route whereby two molecules of farnesylpyrophosphate
(FPP) are condensed to dehydrosqualene by CrtM (59). The
various downstream modification enzymes possess broad sub-
strate specificity and therefore represent potential targets for
generating biosynthetic routes to novel carotenoids. For exam-
ple, when the three-step phytoene desaturase CrtI from
Rhodobacter sphaeroides was replaced with a four-step enzyme
from Erwinia herbicola, the cells accumulated a series of caro-
tenoids produced neither by Erwinia nor Rhodobacter (21).
Carotene desaturases (49), carotene cyclases (54), and -car-
otene cleavage enzyme (50) have also been shown to accept a
broad range of substrates. Combinatorial expression of such
enzymes can create unusual, sometimes previously unidenti-
fied, carotenoids (1, 2, 28). Nevertheless, the greatest potential
to further extend carotenoid biosynthetic diversity lies in cre-
ating whole new backbone structures, and therefore with the
carotene synthases.
The C30 and C40 pathways are very similar except in the sizes
of their precursor molecules and their distributions in nature,
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and it is clear that they diverged from a common ancestral
pathway. We would like to determine the minimal genetic
change required in key carotenoid biosynthetic enzymes to
create such new pathway branches. Can the enzymes that syn-
thesize one carotenoid be modified in a laboratory evolution
experiment to synthesize others? How much of carotenoid
diversity can be accessed in this way? And, can novel pathways
to different, even unnatural, structures (e.g., C35, C45, C50, or
larger carotenoids) be accessed by using C30 or C40 enzymes as
a starting point? To begin to answer these questions, we stud-
ied the performance of the C30 carotene synthase CrtM from
Staphylococcus aureus in a C40 pathway and the C40 carotene
synthase CrtB from Erwinia uredovora in a C30 pathway. We
then examined the ability of these enzymes to adapt to their
respective “foreign” pathways in order to assess the ease and
uncover the mechanisms by which this might be accomplished.
MATERIALS AND METHODS
Materials. The C40 pathway genes crtE (GGPP synthase), crtB (phytoene
synthase), and crtI (phytoene desaturase) from E. uredovora were obtained by
genomic PCR as described previously (53). The E. coli farnesylpyrophosphate
synthase (FPS) gene (fps) was cloned from E. coli strain JM109. The C30 pathway
genes crtM (diapophytoene synthase) and crtN (diapophytoene desaturase) were
cloned by PCR from S. aureus (ATCC 35556) genomic DNA. We used E. coli
XL1-Blue supercompetent cells (Stratagene, La Jolla, Calif.) for cloning, screen-
ing, and carotenoid biosynthesis. AmpliTaq polymerase (Perkin-Elmer, Boston,
Mass.) was employed for mutagenic PCR, while Vent polymerase (New England
Biolabs, Beverly, Mass.) was used for cloning PCR. All chemicals and reagents
used were of the highest available grade.
Plasmid construction. Plasmid pUC18m was constructed by removing the
entire lacZ fragment and multicloning site from pUC18 and inserting the multi-
restriction site sequence 5-CATATG-GAATTC-TCTAGA-CTCGAG-GGGC
CC-GGCGCC-3 (NdeI-EcoRI-XbaI-XhoI-ApaI-EheI). Each open reading
frame following a Shine-Dalgarno ribosomal binding sequence (boldface) and a
spacer (AGGAGGATTACAAA) was cloned into pUC18m to form artificial
operons for acyclic C40 carotenoids (pUC-crtE-crtB-crtI) or acyclic C30 carote-
noids (pUC-fps-crtM-crtN or pUC-crtM-crtN) (the genes in plasmids and operons
are always listed in transcriptional order). To facilitate exchange between the two
pathways, corresponding genes were flanked by the same restriction sites: pre-
nyltransferase genes (fps and crtE) were flanked by EcoRI and XbaI sites, car-
otene synthase genes (crtM and crtB) were flanked by XbaI and XhoI sites, and
carotene desaturase genes (crtN and crtI) were flanked by XhoI and ApaI sites
(Fig. 2a).
FIG. 1. Carotenoid biosynthetic pathways. Carotenoid pathways
are branches of the general isoprenoid pathway. In nature, two dis-
tinctive routes to carotenoid structures are known. C40 pathways,
which start from the head-to-head condensation of two molecules of
GGPP, are found in a variety of plant and microbial species. C30
pathways, which begin with the condensation of two molecules of FPP,
have been identified only in a small number of bacterial species. The
enzyme CrtE is a bacterial GGPP synthase; CrtM and CrtB are bac-
terial carotenoid synthases; CrtN and CrtI are bacterial carotenoid
desaturases. PP, pyrophosphate; GPP, geranylpyrophosphate.
FIG. 2. C30 and C40 production systems used in the paper. (a)
Plasmids used in the work. Under the control of the lac promoter of a
pUC18-derived plasmid, carotene synthase genes (crtB and crtM) were
cloned into an XbaI-XhoI site, along with the prenyltransferase genes
(crtE and fps; EcoRI-XbaI site) and the carotene desaturase genes
(crtN and crtI; XhoI-ApaI site). Listed on the right are the approximate
mole percentages (as a fraction of total carotenoids) of the main
carotenoids produced by E. coli XL1-Blue cells transformed with each
plasmid. Only major species consisting of at least 10% of total caro-
tenoids are shown. (b) Cell pellets of XL1-Blue harboring various
carotenogenic plasmids.
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Error-prone PCR mutagenesis and screening. A pair of primers (5-GCTGC
CGTCAGTTAATCTAGAAGGAGG-3 and 5-AGACGAATTGCCAGTGCC
AGGCCACCG-3) flanking crtM were designed to amplify the 0.85-kb gene by
PCR under mutagenic conditions: 5 U of AmpliTaq (100 l, total volume); 20 ng
of template DNA (entire plasmid); 50 pmol of each primer; 0.2 mM dATP; 1.0
mM (each) dTTP, dGTP, and dCTP; and 5.5 mM MgCl2. Four different muta-
genic libraries were made by using four different MnCl2 concentrations: 0.2, 0.1,
0.05, and 0.02 mM. The temperature cycling scheme was 95°C for 4 min followed
by 30 cycles of 95°C for 30 s, 40°C for 45 s, and 72°C for 2 min and by a final stage
of 72°C for 10 min. PCR yields for the 0.85-kb amplified fragment were 5 g,
corresponding to an amplification factor of 1,000 or 10 effective cycles. The
PCR product from each library was purified with a Zymoclean gel purification kit
(Zymo Research, Orange, Calif.), followed by digestion with XhoI and XbaI and
DpnI treatment to digest the template. The PCR products were ligated into the
carotene synthase gene site of vector pUC-crtE-crtM-crtI, resulting in pUC-crtE-
[crtM]-crtI libraries (square brackets indicate the randomly mutagenized gene).
PCR mutagenesis of crtB on plasmid pUC-crtB-crtN was performed with primers
5-CTTTACACTTTATGCTTCCGG-3 and 5-TCCTGTGACACCTGCACCA
ATTACTGC-3 under the same conditions used for mutagenesis of crtM. The
PCR products were purified, digested, and ligated as described above into the
carotene synthase gene site of pUC-crtB-crtN, resulting in four pUC-[crtB]-crtN
libraries.
The ligation mixtures were transformed into E. coli XL1-Blue supercompetent
cells. Colonies were grown on Luria-Bertani (LB) plates containing carbenicillin
(50 g/ml) as a selective marker at 37°C for 12 h. Colonies were lifted onto white
nitrocellulose membranes (Pall, Port Washington, N.Y.), transferred onto LB-
carbenicillin plates, and visually screened for color variants after an additional 12
to 24 h at room temperature. Selected colonies were picked and cultured over-
night in 96-well plates, each well containing 0.5 ml of liquid LB medium sup-
plemented with carbenicillin (50 g/ml).
Pigment analysis. Among the strains we tested as expression hosts, XL1-Blue
showed the best results in terms of stability and intensity of the color developed
by colonies on agar plates. Although all of the genes assembled in each plasmid
are grouped under a single lac operator/promoter, our expression system showed
no response in terms of pigmentation levels to different IPTG (isopropyl--D-
thiogalactopyranoside) concentrations. Thus, leaky transcription from the lac
promoter was sufficient for carotenoid production in E. coli. Based on this
observation, all experiments described in this paper were performed without
IPTG induction.
To measure the relative amounts of carotenoids synthesized (see Fig. 6), single
colonies were inoculated into 3-ml precultures (LB medium containing 50 g of
carbenicillin/ml) and shaken at 250 rpm and 37°C overnight. Twenty microliters
of each preculture was inoculated into 3 ml of Terrific broth (TB) medium (also
containing 50 g of carbenicillin/ml) and shaken for 24 (C30 carotenoid cultures)
or 30 h (C40 carotenoid cultures) at 250 rpm and 30°C. The optical density at 600
nm (OD600) of each culture was measured immediately before harvesting. Then,
2 ml of each TB culture was centrifuged, the liquid was decanted, and the
resulting cell pellet was extracted with 1 ml of acetone. The absorbance spectrum
of each extract was measured with a SpectraMax Plus 384 microplate spectro-
photometer (Molecular Devices, Sunnyvale, Calif.). Pigmentation levels in the
culture extracts were determined from the height of absorption maxima (max):
470 nm for C30 and 475 nm for C40).
For accurate determination of the carotenoids produced by the cultures, 500
l of LB preculture was inoculated into 50 ml of TB medium (containing 50 g
of carbenicillin/ml) and shaken in a 250-ml tissue culture flask (Becton Dickin-
son-Falcon, Bedford, Mass.) at 170 rpm and 30°C for 24 to 30 h. Cultures
expressing only CrtE plus a carotenoid synthase (CrtB, CrtM, or a mutant CrtM)
were cultivated in 50 ml of TB medium (containing 50 g of carbenicillin/ml) for
40 h at 160 rpm and 28°C in 250-ml tissue culture flasks. The OD600 of each
culture was measured immediately before harvesting, and the dry cell mass was
determined from this measurement by using a calibration curve generated for
similar cultures. After centrifugation, the cell pellets were extracted with 10 ml
of an acetone-methanol mixture (2:1 [vol/vol]). Pigments were concentrated, and
the solvent was replaced with 20 ml of hexane. Then, an equal volume of aqueous
NaCl (100 g/liter) was added, and the mixture was shaken vigorously to remove
oily lipids. The upper phase containing the carotenoids was dewatered with
anhydrous MgSO4 and concentrated in a rotary evaporator. The final volume of
extract from each 50-ml culture was 1 ml. A 30- to 50-l aliquot of extract was
passed through a Spherisorb ODS2 column (250 by 4.6 mm; 5-m pore size;
Waters, Milford, Mass.) and eluted with an acetonitrile-isopropanol mixture
(93:7 or 80:20 [vol/vol]) at a flow rate of 1 ml/min using an Alliance high-pressure
liquid chromatography (HPLC) system (Waters) equipped with a photodiode
array detector. Mass spectra were obtained with a series 1100 HPLC-mass
spectrometer (Hewlett-Packard/Agilent, Palo Alto, Calif.) coupled with an at-
mospheric pressure chemical ionization interface.
The molar quantities of carotenoids shown in Fig. 5 were determined by
comparing HPLC chromatogram peak heights (at 286 nm) to that of a
-carotene standard (at 450 nm) and then multiplying by εbeta-carotene (450 nm)/
εphytoene (286 nm). The values of the molar extinction coefficients (ε) used in the
calculation were 138,900 and 49,800, respectively (7). The molar quantities of
carotenoids were then normalized to the dry cell mass of each culture.
RESULTS AND DISCUSSION
Constructing pathways for C30 and C40 carotenoids. To es-
tablish a recombinant C40 pathway in E. coli, we subcloned crtE
encoding GGPP synthase, crtB encoding phytoene synthase,
and crtI encoding phytoene desaturase, all from E. uredovora,
into a vector derived from pUC18, resulting in plasmid pUC-
crtE-crtB-crtI (Fig. 2a). For C30 carotenoid production, plasmid
pUC-fps-crtM-crtN was constructed by integrating the E. coli
FPS gene (fps) with crtM (dehydrosqualene synthase gene) and
crtN (dehydrosqualene desaturase gene) from S. aureus into
the same vector. Plasmid pUC-crtM-crtN was constructed in an
identical fashion, but it lacks fps. Each plasmid shares the
cloning sites for the corresponding enzyme genes: EcoRI and
XbaI sites flank prenyltransferase genes (crtE and fps), XbaI
and XhoI sites flank carotene synthase genes (crtB and crtM),
and XhoI and ApaI sites flank carotene desaturase genes (crtI
and crtN) (Fig. 2a). With this arrangement, corresponding
genes could be easily swapped in order to evaluate their func-
tion in the other pathway.
E. coli cells harboring pUC-crtE-crtB-crtI plasmids (C40
pathway) developed a characteristic pink color, whereas cells
possessing pUC-fps-crtM-crtN and pUC-crtM-crtN plasmids
(C30 pathway) were yellow (Fig. 2b). HPLC analysis of ex-
tracted pigments showed that XL1-Blue(pUC-crtE-crtB-crtI)
cells produce mostly lycopene (four-step desaturation) along
with a small amount (5 to 10% of total pigment) of 3,4,3,4-
tetradehydrolycopene (six-step desaturation) under the condi-
tions described. Although CrtI is classified as a four-step de-
saturase, production of dehydrolycopene by CrtI both in vivo
and in vitro has been reported (19, 32).
Several groups have expressed CrtM and CrtN from S. au-
reus in E. coli and observed almost exclusive production of
4,4-diaponeurosporene (49, 62). However, in our XL1-Blue-
(pUC-crtM-crtN) expression system, the cells accumulated a
significant amount of 4,4-diapolycopene (30% of total caro-
tenoids). When a constitutive lac promoter (lacking the oper-
ator) was used for operon expression, the amount of 4,4-
diapolycopene increased further and reached 50% of
carotenoids produced (D. Umeno, unpublished data). This
phenomenon was observed in all E. coli strains we tested,
BL21, BL21(DE3), JM109, JM101, DH5	, HB101, SCS110,
and XL10-Gold, and was insensitive to growth temperature
and plasmid copy number. Thus, it is clear that the apparent
desaturation step number of CrtN depends on its expression
level and the effective concentration of substrates.
In E. coli, FPP is a precursor to a variety of important
housekeeping molecules such as respiratory quinones, preny-
lated tRNA, and dolichol. Concerned about retarding or pre-
venting the growth of our recombinant C30 cultures due to
depletion of FPP, we first expressed the fps gene along with
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crtM and crtN. However, we observed no difference in growth
rate, pigmentation level, or carotenoid composition between
XL1-Blue cells harboring the pUC-crtM-crtN plasmid and
those harboring the pUC-fps-crtM-crtN plasmid. This demon-
strates that endogenous FPP levels in E. coli suffice to support
both growth and synthesis of C30 carotenoids.
Functional analysis of CrtM and CrtB swapped into their
respective foreign pathways. To assess the function of wild-
type CrtM in a C40 pathway, pUC-crtE-crtM-crtI was con-
structed and transformed into E. coli XL1-Blue. Under these
circumstances, CrtM is supplied with GGPP produced by CrtE.
If CrtM were able to synthesize the C40 carotenoid phytoene
from GGPP, subsequent desaturation by CrtI to lycopene
would cause the cells to develop a pink color. However, while
cells expressing the crtE-crtB-crtI operon exhibited the charac-
teristic pink of lycopene (Fig. 2b) and synthesized this carot-
enoid in liquid culture (see Fig. 4), cells expressing the crtE-
crtM-crtI operon had only very subtle pink-orange color on
agar plates and synthesized much less lycopene in liquid cul-
ture (see Fig. 4). As did Raisig and Sandmann (49), we thus
conclude that CrtM fails to complement CrtB in a C40 pathway
and has very poor ability compared to CrtB to synthesize the
C40 carotenoid backbone. This observation cannot be ex-
plained by simple competition between FPP and GGPP for
access to CrtM (coupled with poor ability of CrtI to desaturate
the C30 product), because XL1-Blue cells expressing the crtE-
crtM-crtN operon showed only very minor yellow color devel-
opment. This indicates that the availability of FPP for carot-
enoid biosynthesis is significantly reduced upon expression of
CrtE.
The function of CrtB in a C30 pathway was examined by
analyzing the pigmentation of XL1-Blue cells transformed with
pUC-crtB-crtN. In this case, endogenous FPP is the only avail-
able prenylpyrophosphate substrate for CrtB, since GGPP ac-
tivity is not detected in E. coli. If CrtB could synthesize C30
carotenoids from FPP, the 4,4-diapophytoene produced
would be desaturated by CrtN and the cells would develop a
yellow color. In contrast to the intense yellow of XL1-Blue
transformed with pUC-crtM-crtN, XL1-Blue(pUC-crtB-crtN)
showed no color development (Fig. 2b). When expressed alone
or with CrtN, CrtB synthesized C30 carotenoids very poorly in
liquid culture (see Fig. 5 and 6). We thus conclude that CrtB
fails to complement CrtM in a C30 pathway.
We also analyzed the pigment produced by XL1-Blue car-
rying pUC-fps-crtB-crtN. In this case, the cells displayed a yel-
low color similar to that of XL1-Blue transformed with pUC-
fps-crtM-crtN (Fig. 2b). HPLC analysis of carotenoid extracts
from XL1-Blue(pUC-fps-crtB-crtN) revealed the C40 carot-
enoid neurosporene, with trace amounts of the C30 carotenoids
4,4-diapolycopene and 4,4-diaponeurosporene. Thus, CrtB
seems to have at least some C30 activity in the presence of high
levels of FPP. Production of the C40 carotenoid neurosporene
as the major pigment is explained by the promiscuous nature of
both FPS and CrtN. This was verified by our observation that
cells expressing an fps-crtB-crtI operon had a weak pink hue
and accumulated lycopene and 3,4,3,4-tetradehydrolycopene.
Thus, FPS can produce significant amounts of GGPP in E. coli
when overexpressed. It is known that avian FPS also possesses
weak ability to synthesize GGPP (51). Indeed, other studies
have shown a varied product distribution and strong depen-
dence on conditions for FPS enzymes (35, 44). Additionally,
CrtN can accept phytoene as a substrate and introduce two or
three double bonds (49). When we transformed XL1-Blue with
pUC-crtE-crtB-crtN, the resulting cells exhibited significant yel-
low color (Fig. 2b) and accumulated neurosporene, thus dem-
onstrating the promiscuity of CrtN.
Screening for synthase function in a foreign pathway. In the
previous section, we confirmed that the carotene synthases
CrtB and CrtM show negligible activity in their respective
foreign pathways. We next proceeded to evolve the two en-
zymes, with the goal of improving the function of each in the
other’s native pathway. To uncover CrtB variants with signifi-
cant CrtM-like ability to synthesize C30 carotenoids, we con-
structed pUC-[crtB]-crtN libraries and transformed them into
XL1-Blue cells. Here GGPP is not available, so cells with the
wild-type crtB-crtN operon fail to develop color. Any variants
of CrtB able to convert FPP into 4,4-diapophytoene would
produce yellow colonies. Similarly, we searched for CrtM mu-
tants with improved C40 activity by transforming four pUC-
crtE-[crtM]-crtI libraries into XL1-Blue. As described in the
previous section, the amount of FPP available for carotenoid
biosynthesis becomes significantly depleted when CrtE is over-
expressed, resulting in negligible production of C30 carote-
noids, even by native C30 enzymes. Cells expressing wild-type
CrtM from the crtE-crtM-crtI operon showed a weak pink-
orange color due to trace production of C30 and C35 carote-
noids, but CrtM mutants able to complement CrtB via en-
hanced C40 activity would be expected to yield intensely pink
colonies and thus be distinguishable on the plates.
Evolution of dehydrosqualene synthase (CrtM) for function
in a C40 pathway. Four different mutagenic libraries of crtM
corresponding to four different mutation rates were generated
by performing error-prone PCR (65) on the entire 843-nucle-
otide crtM gene. PCR products from each reaction were ligated
into the XbaI-XhoI site of pUC-crtE-crtM-crtI (Fig. 2), result-
ing in pUC-crtE-[crtM]-crtI libraries. Figure 3 shows a typical
agar plate covered with a nitrocellulose membrane upon which
lie colonies of E. coli XL1-Blue expressing a crtE-[crtM]-crtI
library. In each library, colonies with pale orange, pale yellow,
or virtually no color dominated the population. The pale or-
ange colonies express variants of CrtM with phenotypes similar
to that of the wild-type enzyme in this context, while the pale
and colorless colonies express severely or completely inacti-
vated synthase mutants. More rare were colonies that devel-
oped an intense red-pink color, indicating significant produc-
tion of C40 carotenoids and hence improved CrtB-like activity
of CrtM. On average, about 0.5% of the colonies screened
showed intense red-pink color. The highest frequency of pos-
itives was obtained from the library prepared by PCR with the
lowest MnCl2 concentration (0.02 mM). In this library, approx-
imately 1 out of every 120 colonies was red-pink (0.8%). We
screened over 23,000 CrtM mutants from the four libraries and
picked 116 positive clones. These clones were rescreened by
stamping them onto an agar plate covered with a white nitro-
cellulose membrane. All 116 stamped clones exhibited red-
pink coloration. We sequenced the 10 most intensely red
stamped clones, as determined by visual assessment. Mutations
found in these variants (Table 1) were heavily biased toward
transitions: 36 versus only 3 transversions. Additionally, 87%
of the base substitutions found by sequencing were A/T3G/C.
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This is a typical observation for PCR mutagenesis with MnCl2
(10, 33). Out of 39 total nucleotide substitutions, 24 resulted in
amino acid substitutions. Most notably, 9 of the 10 sequenced
CrtM mutants had a mutation at phenylalanine 26.
Carotenoid production of evolved CrtM variants. We ana-
lyzed in detail the in vivo carotenoid production of variant M8,
which has the F26L mutation only, variant M9, which has the
F26S mutation, and variant M10, which has no mutation at F26.
To confirm the newly acquired CrtB-like function of these
three sequenced variants of CrtM, XL1-Blue cultures carrying
each of the three plasmids pUC-crtE-M8-crtI, pUC-crtE-M9-
crtI, and pUC-crtE-M10-crtI (collectively referred to as pUC-
crtE-M8-10-crtI) were cultivated in TB media. Extracted pig-
ments were analyzed by HPLC with a photodiode array
detector (Fig. 4). These analyses revealed that all three clones
produced the C40 carotenoids lycopene (peak 5) and 3,4,3,4-
tetradehydrolycopene (peak 4) as major products, whereas
cells harboring the parent pUC-crtE-crtM-crtI plasmid pro-
duced mainly C30 and trace amounts of C40 and C35 carote-
noids. Two carotenoids with C35 backbone structures were
detected in extracts from cells harboring pUC-crtE-crtM-crtI
and pUC-crtE-M8-10-crtI. Elution profiles, UV-visible spectra,
and mass spectra confirm that one of the structures is the fully
conjugated C35 carotenoid 4-apo-3,4-didehydrolycopene. We
also detected C35 carotenoids with 11 conjugated double
bonds. Because C35 carotenoids are asymmetric, there are two
possible C35 structures that possess 11 conjugated double
bonds: 4-apolycopene and 4-apo-3,4-didehydro-7,8-dihy-
drolycopene. At present, we have not determined whether the
cells synthesize one (and if so, which one) or both of these C35
carotenoids.
Direct product distribution of CrtM variants in the pres-
ence of GGPP. To directly evaluate the product specificities of
the three CrtM mutants, we constructed pUC-crtE-M8-10 plas-
mids and transformed the plasmids into XL1-Blue cells. Here
the CrtM variants are supplied with GGPP, but the carotenoid
products cannot be desaturated. Because all three possible
products in this scenario, 4,4-diapophytoene (C30), 4-apophy-
toene (C35), and phytoene (C40), have an identical chro-
mophore structure consisting of three conjugated double
bonds, the molecular extinction coefficients for all three can be
assumed to be equivalent, irrespective of the total number of
carbon atoms in the carotenoid molecule (60). Thus, the prod-
uct distribution of the CrtM variants can be discerned from the
HPLC chromatogram peak heights (at 286 nm) for each prod-
uct. As can be seen in Fig. 5, cultures expressing CrtB along
with CrtE produced approximately 230 nmol of phytoene/g of
dry cell mass but did not detectably synthesize C30 or C35
carotenoids. CrtE-CrtM cultures produced about 20 to 35
nmol of each of the C30, C35, and C40 carotenoids/g. In stark
contrast, CrtE-M8 and CrtE-M9 cultures, which express syn-
thases mutated at F26, generated over 300 nmol of phytoene/g.
These cultures also produced 40 to 75% more C35 carotenoids
but 70 to 90% fewer C30 carotenoids than CrtE-CrtM cultures.
Cultures expressing M10, which has no mutation at F26, along
with CrtE synthesized roughly 100 nmol of phytoene/g as well
as about 20 and 14 nmol of C35 and C30 carotenoids/g, respec-
tively.
Comparison of the C40 and C30 performance of CrtM vari-
ants. To compare the acquired CrtB-like C40 function of the
CrtM mutants with their CrtM-like ability to synthesize C30
carotenoids, the three mutants were placed back into the orig-
inal C30 pathway, resulting in pUC-M8-10-crtN plasmids. Pig-
mentation analysis of cells carrying these as well as pUC-crtE-
M8-10-crtI plasmids (Fig. 6) revealed that the CrtM variants
retained C30 activity, although the C30 pathway performance of
cells expressing these mutants varied. Acetone extracts of cul-
tures expressing variant M8, which has the F26L mutation
FIG. 3. Typical plate with E. coli XL1-Blue colonies expressing a
mutagenic library of CrtM together with CrtI and CrtE. XL1-Blue cells
were transformed with pUC-crtE-[crtM]-crtI (E[M]I), where [crtM]
represents a mutagenic library of crtM. Among a majority of pale
colonies can be seen deep pink colonies (arrows) expressing CrtM
variants that have acquired C40 pathway functionality. EMI and EBI,
XL1-Blue cells transformed with pUC-crtE-crtM-crtI and pUC-crtE-
crtB-crtI, respectively.
TABLE 1. Mutations found in sequenced CrtM variants
Mutant
Mutation(s)
Nonsynonymous
(amino acid change) Synonymous
M1 T76C (F26L), A364T (T122S) A561G
M2 A58G (K20E), T77C (F26S) A471T
M3 T76C (F26L), G127A (V43M) A408G, T847C
M4 T76C (F26L), A446G (E149G) T150C, G489A,
A726G, A850G
M5 T76C (F26L), T800C (F267S)
M6 A35G (H12R), T76C (F26L),
A80G (D27G), A290G
(K97R), A620G (H207R)
A688G
M7 T76C (F26L) A186G, A447G
M8 T78A (F26L) A345G
M9 T77C (F26S), T119C (I40T) T135C, T141C
M10 A10G (M4V), A35G (H12R),
T176C (F59S), A242G
(Q81R), A539G (E180G)
A39G
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alone, along with CrtE and CrtI (CrtE-M8-CrtI cultures) had
more than threefold-higher C40 carotenoid absorbance (475
nm) than extracts of CrtE-CrtM-CrtI cultures. However, the
C30 carotenoid absorbance (470 nm) of extracts of cultures
expressing variant M8 and CrtN was only about 40% that of
CrtM-CrtN cultures. Cultures expressing variant M9, which has
the F26S mutation, along with CrtE and CrtI also yielded
extracts with over three times the C40 signal of CrtE-CrtM-CrtI
culture extracts. Yet the C30 signal of M9-CrtN culture extracts
was only about 10% that of CrtM-CrtN culture extracts. Cul-
tures expressing mutant M10, which has no mutation at F26,
along with CrtE and CrtI generated extracts with approxi-
mately 70% higher C40 absorbance than extracts of CrtE-
CrtM-CrtI cultures. Interestingly, cultures expressing M10 and
CrtN showed no reduction in C30 pathway performance com-
pared to CrtM-CrtN cultures. M10 was the only 1 of the 10
sequenced variants that gave this result (data not shown).
Analysis of mutations. The most significant and only recur-
ring mutations found in the 10 sequenced CrtM variants were
those at F26. In seven variants, phenylalanine is replaced by
leucine, while two have serine at this position. The F26L sub-
stitution alone is sufficient for acquisition of C40 activity by
CrtM (M8; Table 1). Thus, we conclude that mutation at res-
idue 26 of CrtM directly alters the enzyme’s specificity. Chang-
ing enzyme expression level or stability would not lead to
increased C40 performance and decreased C30 performance of
cultures expressing CrtM variants compared to those express-
ing wild-type CrtM (Fig. 6). Variant M10 possesses no muta-
tion at amino acid position 26. Thus, it is apparent that muta-FIG. 4. HPLC-photodiode array analysis of carotenoid extracts of
E. coli transformants carrying plasmids pUC-crtE-crtB-crtI, pUC-crtE-
crtM-crtI, and pUC-crtE-M8-10-crtI. The following carotenoids were
identified: peak 1, 4,4-diaponeurosporene (max [nm]: 467, 438, 414,
M at m/e 
 402.4); peak 2, 4-apo-34-didehydrolycopene (max [nm]:
527, 490, 465, M at m/e 
 466.4); peak 3, 4-apolycopene or 4-apo-
34-didehydro-7,8-dihydrolycopene (max [nm]: 500, 470, 441, M
 at
m/e 
 468.4); peak 4, 3,4,3,4-tetradehydrolycopene (max [nm]: 540,
FIG. 5. Direct product distribution of CrtM and its mutants in the
presence of CrtE (GGPP supply). Carotenoid extracts of XL1-Blue
cells carrying plasmids pUC-crtE-crtB, pUC-crtE-crtM, and pUC-crtE-
M8-10 were analyzed by HPLC with a photodiode array detector. Peaks
for 4,4-diapophytoene (C30), 4-apophytoene (C35), and phytoene
(C40) were monitored at 286 nm. Molar quantities of the various
carotenoids were determined as described in Materials and Methods.
Bar heights are normalized to dry cell mass and represent the averages
of three replicates; error bars, standard deviations.
510, 480, M at m/e 
 532.4); peak 5, lycopene (max [nm]: 502, 470,
445, M at m/e 
 536.5). Double peaks indicate different geometrical
isomers of the same compound. Insets, recorded absorption spectra of
individual HPLC peaks.
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tion at this residue is not the only means by which CrtM can
acquire CrtB-like activity. Of all 10 sequenced variants, M10 is
the only one with no substitution for phenylalanine at position
26 and is also the only one whose cultures did not have de-
creased C30 pathway performance compared to CrtM cultures.
Structural considerations: mapping mutations onto human
SqS. Most structurally characterized isoprenoid biosynthetic
enzymes, including FPS, squalene synthase (SqS), and terpene
cyclases, have the same “isoprenoid synthase fold,” consisting
predominantly of 	-helices (31). In addition, secondary struc-
ture prediction (14) and sequence alignment (11) of CrtM and
CrtB with their related enzymes also suggest that the enzymes
have a common fold. Given this and the lack of a crystal
structure for a carotenoid synthase, we mapped the amino acid
substitutions in our CrtM variants onto the crystal structure of
human SqS (47).
SqSs catalyze the first committed step in cholesterol biosyn-
thesis. As with carotene synthases, this is the head-to-head
condensation of two identical prenylpyrophosphates (FPP for
SqS). The condensation reaction catalyzed by SqS proceeds in
two distinct steps (48). The first half-reaction generates the
stable intermediate presqualene pyrophosphate, which forms
upon abstraction of a pyrophosphate group from a prenyl
donor, followed by 1-1 condensation of the donor and accep-
tor molecules. In the second half-reaction, the intermediate
undergoes a complex rearrangement followed by a second re-
moval of pyrophosphate and a final carbocation-quenching
process (Fig. 7). SqSs catalyze the additional reduction of the
central double bond of dehydrosqualene by NADPH to form
squalene, a reaction not performed by carotene synthases. Be-
cause the SqS and carotene synthase enzymes share clusters of
conserved amino acids and catalyze essentially identical reac-
tions, it is probable that they also have the same reaction
mechanism. Indeed, when NADPH is in short supply, SqS
produces dehydrosqualene, the natural product of CrtM (26,
63).
Sequence alignment of CrtM with related enzymes implies
that F26 in CrtM corresponds to I58 in human SqS, which is
located in helix B and points into the pocket that accommo-
dates the second half-reaction. This residue is located four
amino acids downstream of a flexible “flap” region in SqS that
is believed to form a “lid” that shields intermediates in the
reaction pocket from water (47). The amino acids constituting
the flap are almost completely conserved among all known
head-to-head isoprenoid synthase enzymes that catalyze 1-1
condensation.
It is noteworthy that a single mutation at F26 of CrtM is
sufficient to permit this enzyme to synthesize C40 carotenoids.
Because this position is thought to lie in the site of the second
half-reaction (rearrangement and quenching of a cyclopropyl-
carbinyl intermediate) (47) and because wild-type CrtM pro-
duces trace amounts of phytoene (indicating that initially ac-
cepting two molecules of GGPP is not impossible), it is likely
that wild-type CrtM is able to perform the first half-reaction of
phytoene synthesis (condensation of two molecules of GGPP
to form a presqualene pyrophosphate-like structure). We hy-
pothesize that the F26 residue prevents the second half-reac-
tion from going to completion by acting as a steric or electro-
static inhibitor of intermediate rearrangement. When this
bulky phenylalanine residue is replaced with a smaller or more
flexible amino acid such as serine or leucine, the second half-
reaction is permitted to proceed and phytoene is produced.
Similar results for a variety of short-chain prenyltransferases
have been reported. In this class of enzymes, the size of the
fifth amino acid upstream of the first aspartate-rich motif de-
termines product length (39, 42, 43, 45, 46). Based on a very
strong correlation between average product length and surface
FIG. 6. Pigmentation produced by CrtM variants in C40 and C30
pathways. XL1-Blue cells were transformed with either pUC-crtE-M8-
10-crtI (C40 pathway) or pUC-M8-10-crtN (C30 pathway) and cultured in
a test tube (3 ml of TB) as described in Materials and Methods.
Pigmentation levels in the culture extracts were determined from the
absorption peak height of max (470 nm for C30, 475 nm for C40) of
each sample. Bar heights are normalized to OD600 and represent the
averages of at least three replicates; error bars, standard deviations.
FIG. 7. Reaction schemes for SqS and CrtM. PSPP, presqualene
pyrophosphate.
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area of amino acids in this position (46), as well as the available
crystal structure for avian FPS (58), it was hypothesized that
this residue forms a steric barrier or wall that controls the size
of the products (40). This model has been successfully applied
to a variety of other enzymes in this family, including medium-
chain prenyltransferases (64). It is unknown why so many pre-
nyltransferases differing so greatly in sequence share a single
key residue that determines product specificity.
Evolution of phytoene synthase (CrtB) in a C30 pathway. We
constructed mutant libraries of crtB to search for variants with
C30 activity. Four mutagenic PCR libraries differing in MnCl2
concentration were ligated into the XbaI-XhoI site of pUC-
crtB-crtN, resulting in four pUC-[crtB]-crtN plasmid libraries.
Upon transformation into XL1-Blue, pUC-crtB-crtN, contain-
ing wild-type crtB, gave no discernible pigmentation, while the
pUC-crtM-crtN cells produced had intense yellow pigmenta-
tion. Among the 43,000 colonies expressing pUC-[crtB]-crtN
variants screened, not a single one showed distinguishable yel-
low (or other) pigmentation. Thus, we found no CrtB mutants
with improved C30 activity. We also constructed five additional
pUC-[crtB]-crtN libraries by using the Genemorph PCR mu-
tagenesis kit (Stratagene), which enables the construction of
randomly mutagenized gene libraries with a mutational spec-
trum different from that of those generated by mutagenic PCR
with MnCl2 (10). We screened an additional 10,000 variants
but again found no variants of CrtB able to synthesize C30
carotenoids at appreciable levels.
An explanation for the relative difficulty in acquiring C30
function for CrtB may be that accepting a smaller-than-natural
substrate is a more difficult task for this type of enzyme than
accepting a larger-than-natural substrate. However, an evolu-
tionary explanation may also be in order. The contexts in which
the two enzymes evolved differ markedly. FPP is a precursor
for many life-supporting compounds and is present in all or-
ganisms. Thus, C40 enzymes such as CrtB have evolved in the
presence of FPP throughout their history. It is not unreason-
able to infer that CrtB has evolved under a nontrivial selection
pressure to minimize consumption of FPP, for accepting FPP
as a substrate and bypassing GGPP could be detrimental to the
host organism’s fitness. In stark contrast, C30 synthases have
evolved in an environment essentially devoid of GGPP. Con-
sequently, no pressure to reject this substrate has been placed
on these enzymes.
It has been suggested that secondary metabolic pathways
possess inherent traits that enhance their ability to produce
chemical diversity and thus maximize their likelihood of ac-
cessing biologically active molecules (18, 27). This hypothesis
would be supported by a high degree of “evolvability” of the
constituent enzymes. The substrate and product specificities of
the isoprenoid biosynthetic enzymes, specifically carotene syn-
thases, are, in fact, easily modified. Product formation in this
class of enzymes is determined primarily by the rearrangement
and quenching of a highly reactive carbocation intermediate
(31). Therefore, many products are possible from a single
intermediate, and the main role of the synthase enzyme is to
guide the rearrangement process. Because this process is very
sensitive to small changes in the local chemical environment,
many different amino acid substitutions would be expected to
alter the product specificity of a carotenoid synthase. Thus,
directed evolution of this class of enzymes appears to be a
powerful tool for exploring a variety of different chemical
structures in the laboratory.
In our experiments and with our expression system, carotene
synthases CrtM and CrtB failed to function in their respective
foreign pathways. However, upon random mutagenesis of crtM
followed by C40-specific color complementation screening, we
isolated 116 mutants of the enzyme (0.5% of the total
screened) with significant C40 activity. The in vivo C40 pathway
performance of the best CrtM variants is comparable to that of
CrtB, the native C40 synthase. These results do not stand in
isolation; such relative ease of altering specificity has been
reported for other isoprenoid biosynthetic enzymes (4, 8, 9, 15,
16, 20, 22, 23, 29, 30, 34, 42, 43, 45, 46, 53, 57).
We have shown for the first time that the substrate and
product range of a carotene synthase can be easily altered in
the laboratory by directed evolution. That the C30 carotenoid
synthase CrtM, a key biosynthetic enzyme that determines the
size of the carotenoids in the downstream pathway, is a mere
single base substitution from becoming a C40 synthase is a
finding of evolutionary and technological significance. How
many more mutations need to accumulate before CrtM is
completely transformed into a C40-only synthase? Can CrtM or
CrtB be made to convert substrates other than FPP and
GGPP? These and other questions should be answered by
further laboratory evolution of carotenoid synthases.
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